Kairos Ventures, based in Beverly Hills, California, is a Venture Fund established in 2015. They focus on Pre-Seed, Seed, and Series A stages, specializing in BioTech, Healthcare, and Pharmaceuticals. With 53 investments and 3 exits, Kairos Ventures, led by partner Nikos Iatropoulos, invests in innovative ideas, patents, and businesses from top universities and scientists. One of their portfolio companies is Novosteo. For more information, visit their website at www.kairosventures.com.